Back in January, TrialSite’s founder Daniel O’Connor spoke with Gary A. Ulaner, MD, PhD, FACNM, director of the Hoag Molecular Imaging and Therapy Program, about the emergence of Hoag Memorial…
During the pandemic, TrialSite has reported multiple times on the potential for NeuroRX’s RLF-100 (aviptadil) currently under investigation and accessible under the U.S. Food and…
Led by the University of California, Los Angeles (UCLA), a coalition of 11 academic institutions and their community partners across California were afforded the opportunity…
Hoag Memorial Hospital Presbyterian became the only hospital in Orange County, and one of the first in the nation, to provide oncologists with the technology to…
Imperial County’s El Centro Regional Medical Center (ECRMC) will be participating in yet another clinical trial battling COVID-19. The health system in the very southern…
Paradigm Clinical Research Centers Inc. (Paradigm Research) in Redding, California, was selected to participate in both the Moderna mRNA-1273 and the Pfizer/BioNTech forthcoming Phase 3…
Just as the death toll from COVID-19 rose over 90,000 in the United States, Operation Warp Speed was announced by President Donald Trump, an ambitious…
Elligo Health Research, a Texas-based research organization emphasizing models supporting clinical research-as-a-care-option, has inked an alliance with health data specialists Verily (part of Google) to support…
A growing number of healthcare professionals become optimistic about Gilead’s remdesivir as a possible treatment to at least slow down the SARS-CoV-2 virus in patients. Many…
Cedars-Sinai, Los Angeles is actively participating in the remdesivir clinical trial as an experimental class of treatment for COVID-19. The prominent Southern California-based provider is…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
